Inhibrx Biosciences, Inc. Made Big Gain
Wed, Apr 22, 2026 at 07:24 PM
Inhibrx Biosciences, Inc. (INBX:NASDAQ) soared at $115.09, representing a gain of 36.9%. On Wed, Apr 22, 2026, INBX:NASDAQ hit a New 2-Week High of $115.09. The stock got featured on our News Catalysts scanner on Wed, Apr 22, 2026 at 01:12 PM in the 'MISCELLANEOUS' category. From Wed, Apr 08, 2026, the stock recorded 70.00% Up Days and 45.45% Green Days
The stock spiked on Wed, Apr 22, 2026 at $155.29 with a volume of 2M+.
About Inhibrx Biosciences, Inc. (INBX:NASDAQ)
Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates.
Top 10 Gainers:
- Akanda Corp. (AKAN:NASDAQ), 214.15%
- Axe Compute Inc. (AGPU:NASDAQ), 79.3%
- Toro Corp. (TORO:NASDAQ), 72.76%
- Elong Power Holding Limited (ELPW:NASDAQ), 66.77%
- Xanadu Quantum Technologies Limited (XNDU:NASDAQ), 51.75%
- Huachen AI Parking Management Technology Holding Co., Ltd (HCAI:NASDAQ), 43.45%
- Greenlane Holdings, Inc. (GNLN:NASDAQ), 40.36%
- Lianhe Sowell International Group Ltd (LHSW:NASDAQ), 38.27%
- Inhibrx Biosciences, Inc. (INBX:NASDAQ), 36.88%
- GameSquare Holdings, Inc. (GAME:NASDAQ), 33.86%